Lung cancer UPDATE: July 14-20, 2016 || Public Health Genomics Knowledge Base (v1.0)

Public Health Genomics Knowledge Base (v1.0)

July 14-20, 2016

Last Updated: Jul 15, 2016

• Air bronchogram: A potential indicator of epidermal growth factor receptor mutation in pulmonary subsolid nodules.
  Dai Jie, et al. Lung cancer (Amsterdam, Netherlands) 2016 8 22-8
• Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.
  Zanetti Krista A, et al. Lung cancer (Amsterdam, Netherlands) 2016 8 33-42
• Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer.
  Mok Tony, et al. Lung cancer (Amsterdam, Netherlands) 2016 8 1-8
• EGFR Testing in Advanced Non-Small-Cell Lung Cancer, A Mini-Review.
  Sheikine Yuri et al. Clinical lung cancer 2016 Jun
• Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed.
  Park Sojung, et al. BMC cancer 2016 0 417
• Epidermal growth factor receptor-tyrosine kinase inhibitor therapy is especially beneficial to patients with exon 19 deletion compared with exon 21 L858R mutation in non-small-cell lung cancer: Systematic review and meta analysis.
  Liu Yinghui, et al. Thoracic cancer 2016 7 (4) 406-14
• Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot study.
  Pu Dan, et al. Thoracic cancer 2016 7 (4) 428-36
• Gefitinib for asymptomatic brain metastasis from advanced non-small cell lung cancer: Report of a favourable outcome.
  Liu Wen-Yang, et al. Thoracic cancer 2016 7 (4) 498-502
• Pilot study of radiofrequency hyperthermia in combination with gefitinib in gefitinib-effective patients with advanced NSCLC.
  Qin Yijia, et al. Thoracic cancer 2016 7 (4) 422-7
• Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B).
  Fukuda Minoru, et al. Thoracic cancer 2016 7 (4) 467-72
• Nontuberculous Mycobacteria Infection and Prognosis after Surgery of Lung Cancer: A Retrospective Study.
  Yamanashi Keiji, et al. The Thoracic and cardiovascular surgeon 2016 7
• Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk.
  Xie Kaipeng, et al. Oncotarget 2016 6
• USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs.
  Malapelle Umberto, et al. Lung cancer (Amsterdam, Netherlands) 2016 6
• Comparison of plasma and tissue samples in epidermal growth factor receptor mutation by ARMS in advanced non-small cell lung cancer.
  Ma MeiLi, et al. Gene 2016 6
• Impact of active smoking on survival of patients with metastatic lung adenocarcinoma harboring an epidermal growth factor receptor (EGFR) mutation.
  Erdogan Bulent, et al. Bosnian journal of basic medical sciences / Udruzenje basicnih mediciniskih znanosti = Association of Basic Medical Sciences 2016 7

• CDC Information (2)
• CDC-Authored Pub (7)

• Human (30)
• Pathogen (0)

• Human (3851)
• Pathogen (0)

• Human (60)
• Pathogen (0)

• Guidelines (8)
• Tier Table (4)
• Synthesis (10)

• Huamn (4)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB